Skip NavigationDepartment of Transportation Logo  U.S. Department of Transportation Keyword Links | Contact Us | Español

Federal Motor Carrier Safety Administration

Home Rules & Regulations Registration & Licensing Forms Safety & Security Facts & Research Cross Border About FMCSA
  Home > Rules & Regulations > Regulations
Overview
Federal Regulations
All
Driver
Vehicle
Company
FMCSA Hazmat
Regulatory Guidance
Rulemakings and Notices
Final Rules
Interim Final Rules
Proposed Rules
Notices
Topics of Interest
Hours of Service (HOS)
Hazardous Materials
Medical Program
NAFTA Rules
Drug & Alcohol Testing
 
  

Regulations

  Print this page Print    

40.139   On what basis does the MRO verify test results involving opiates?


As the MRO, you must proceed as follows when you receive a laboratory confirmed positive opiate result:

(a) If the laboratory detects the presence of 6-acetylmorphine (6-AM) in the specimen, you must verify the test result positive.

(b) In the absence of 6-AM, if the laboratory detects the presence of either morphine or codeine at 15,000 ng/mL or above, you must verify the test result positive unless the employee presents a legitimate medical explanation for the presence of the drug or drug metabolite in his or her system, as in the case of other drugs (see 40.137 ). Consumption of food products ( e.g. , poppy seeds) must not be considered a legitimate medical explanation for the employee having morphine or codeine at these concentrations.

(c) For all other opiate positive results, you must verify a confirmed positive test result for opiates only if you determine that there is clinical evidence, in addition to the urine test, of unauthorized use of any opium, opiate, or opium derivative (i.e., morphine, heroin, or codeine).

(c)(1) As an MRO, it is your responsibility to use your best professional and ethical judgement and discretion to determine whether there is clinical evidence of unauthorized use of opiates. Examples of information that you may consider in making this judgement include, but are not limited to, the following:

(c)(1)(i) Recent needle tracks;

(c)(1)(ii) Behavioral and psychological signs of acute opiate intoxication or withdrawal;

(c)(1)(iii) Clinical history of unauthorized use recent enough to have produced the laboratory test result;

(c)(1)(iv) Use of a medication from a foreign country. See 40.137(e) for guidance on how to make this determination.

(c)(2) In order to establish the clinical evidence referenced in paragraphs (c)(1)(i) and (ii) of this section, personal observation of the employee is essential.

(c)(2)(i) Therefore, you, as the MRO, must conduct, or cause another physician to conduct, a face-to-face examination of the employee.

(c)(2)(ii) No face-to-face examination is needed in establishing the clinical evidence referenced in paragraph (c)(1)(iii) or (iv) of this section.

(c)(3) To be the basis of a verified positive result for opiates, the clinical evidence you find must concern a drug that the laboratory found in the specimen. (For example, if the test confirmed the presence of codeine, and the employee admits to unauthorized use of hydrocodone, you do not have grounds for verifying the test positive. The admission must be for the substance that was found).

(c)(4) As the MRO, you have the burden of establishing that there is clinical evidence of unauthorized use of opiates referenced in this paragraph (c) . If you cannot make this determination ( e.g. , there is not sufficient clinical evidence or history), you must verify the test as negative. The employee does not need to show you that a legitimate medical explanation exists if no clinical evidence is established.


Go To Top of Page